← Back to Search

Cancer Vaccine

Homeopathic Vaccines for Healthy Subjects (HVT Trial)

Phase 4
Waitlist Available
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 24 years
Has received primary childhood DTaP and MMR vaccinations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

HVT Trial Summary

This trial will compare the effectiveness of homeopathic vaccines to placebo and conventional vaccines in young adults.

Who is the study for?
This trial is for healthy young adults aged 18-24 who've had their childhood DTaP and MMR shots. They must be able to return for a follow-up visit. People can't join if they're allergic to vaccine components, recently had certain vaccines or immune treatments, are pregnant, have serious health issues like cancer or HIV/AIDS, or could get pregnant within a month.Check my eligibility
What is being tested?
The study tests how the body's immune system responds to homeopathic vaccines (like Diphtherinum®, Tetanotxicum®, Morbilinum®) compared to placebo (sugar pellets, saline) and conventional vaccines (Tdap, MMR). Participants will receive one of these interventions randomly.See study design
What are the potential side effects?
Homeopathic vaccines typically have fewer side effects than conventional ones; however, some may experience minor reactions at the injection site or mild flu-like symptoms. Conventional vaccines might cause soreness where the shot was given, fever, fatigue or headache.

HVT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 24 years old.
Select...
I received DTaP and MMR vaccines as a child.

HVT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antibody levels for diphtheria
Antibody levels for measles
Antibody levels for mumps
+2 more

HVT Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Homeopathic vaccine groupExperimental Treatment6 Interventions
Diphtheria (Diphtherinum®), pertussis (Pertussinum®), tetanus (Tetanotxicum®), measles (Morbilinum®) and mumps (Ourlianum®) nosodes. Two sterile saline injections (0.5ml each, intramuscular and subcutaneous) as placebo.
Group II: Conventional vaccine groupActive Control3 Interventions
One intramuscular dose of Tdap (tetanus, diphtheria, acellular pertussis) One subcutaneous dose of MMR (measles, mumps, rubella) Sugar pellets as placebo.
Group III: Control groupPlacebo Group2 Interventions
Sugar pellets oral dose Two sterile saline injections (0.5 ml each, intramuscular and subcutaneous) as placebo

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,828 Total Patients Enrolled

Media Library

Diphtherinum® (Cancer Vaccine) Clinical Trial Eligibility Overview. Trial Name: NCT02825368 — Phase 4
Healthy Subjects Research Study Groups: Control group, Homeopathic vaccine group, Conventional vaccine group
Healthy Subjects Clinical Trial 2023: Diphtherinum® Highlights & Side Effects. Trial Name: NCT02825368 — Phase 4
Diphtherinum® (Cancer Vaccine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02825368 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being considered for enrollment into this trial?

"Per the terms of this clinical trial, individuals aged 18-24 are eligible for enrollment."

Answered by AI

Is there an opportunity for participants to join this clinical experiment presently?

"Unfortunately, this treatment trial is not currently gathering participants. It was initially posted on the first of September 2016 and its information was last updated on August 3rd 2017. Despite that, 841 other medical studies are actively looking for volunteers at the present time."

Answered by AI

Has Diphtherinum® been sanctioned by the FDA?

"The safety of Diphtherinum® is rated a 3 out of 3 based on the fact that it has passed Phase 4 clinical trials and been officially approved."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Homeopathic Vaccine Trial
2016. "Homeopathic Vaccine Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02825368.
~41 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top